Glatiramer Injection

A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Contract (Goods)
Duration
0.5 year
Value
£12M
Sector
HEALTH
Published
19 Aug 2022
Delivery
To 15 Feb 2023 (est.)
Deadline
n/a

Concepts

Location

Scotland:

Geochart for 1 buyers and 2 suppliers

1 buyer

2 suppliers

Description

Total Quantity or Scope

This modification of contract term from 01/09/2022 to 28/02/2023 is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 Modification notice is advised at framework level and does not detail individual lots.

Award Detail

1 Teva (Castleford)
  • Glatiramer Injection
  • Reference: 023055-2022-np47818-1
  • Value: £12,005,839 [share]
  • Awarded to group of suppliers.
2 Mylan (Hatfield)
  • Glatiramer Injection
  • Reference: 023055-2022-np47818-1
  • Value: £12,005,839 [share]
  • Awarded to group of suppliers.

CPV Codes

  • 33600000 - Pharmaceutical products
  • 33661000 - Medicinal products for the nervous system

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value of two (2) Lots referred to in Section V.2.4 covers the thirty-six (36) months of the framework length and fifteen (15) months extension period of the framework agreement. (SC Ref:702140)

Reference

Domains